Orthopedic Regenerative Surgical Products Market Size [2031]

Report Description

Orthopedic Regenerative Surgical Products Market Outlook 2031.

The global orthopedic regenerative surgical products market size was USD 4.25 Billion in 2022 and is likely to reach USD 5.65 Billion by 2031, expanding at a CAGR of 4% during 2023–2031. The market growth is attributed to the rising incidence of osteoarthritis in aging people.

Increasing prevalence of osteoarthritis in the geriatric population is expected to fuel the orthopedic regenerative surgical products market in the coming years. Osteoarthritis affects the elderly, as the cartilage that cushions the end of the bones deteriorates over time.

It affects any joint and commonly occurs in the knee, hip, and spine. Older adults have a higher risk of accidents such as falls and osteoporosis, which increases the risk of fractures, which in turn, is expected to boost the market.

• According to the World Health Organization (WHO) around 528 million individuals were living with osteoarthritis worldwide in 2019. Around 73% of individuals living with osteoarthritis are older than 55 years and 60% are female.

Get Free Sample Report

The market report finds that the COVID-19 pandemic hindered the market, due to the strict lockdown imposed by the government. Disruption of the supply chain and the cancellation of elective procedures impact the market during the pandemic. Orthopedic regenerative surgical products faced challenges, owing to business closures, travel restrictions, and social distancing.

Impact of Artificial Intelligence on Orthopedic Regenerative Surgical Products Market

Artificial intelligence (AI) technologies are expected to boost the orthopedic regenerative surgical products market during the forecast period. AI makes inroads into the field of orthopedic regenerative medicine.

AI systems are developed to help with the diagnosis and treatment of orthopedic conditions and to improve patient outcomes. Some of the applications of AI in orthopedic surgery include automated diagnosis, preoperative planning, surgical assistance, and postoperative monitoring.

Orthopedic Regenerative Surgical Products Market Dynamics

Get Free Sample Report

Major Drivers

Rising prevalence of arthritis and orthopedic surgeries is expected to drive the market. Regenerative medicine is promising that uses biological treatments to improve symptoms of certain orthopedic conditions and has the potential to enhance healing in musculoskeletal tissues.

Regenerative orthopedics improves pain and discomfort in the musculoskeletal system and enhances the healing of orthopedic conditions such as injuries of a tendon, spinal disc, ligament, muscle, bone, cartilage, meniscus of the knee, and other musculoskeletal tissue.

• According to the report published by the WHO, in 2022 approximately 1.71 million individuals have musculoskeletal conditions all over the world.

Increasing technological advancements in launching new surgical products is expected to boost the orthopedic regenerative surgical products market during the forecast period. Several companies are introducing new technologies such as stem cells, viscosupplements, and platelet rich plasma therapies.

These technologies help the elder reduce their pain and swelling in arthritic joints. The use of platelet rich plasma therapies helps damaged joints, tendons, ligaments, or muscles, as several companies are introducing new technologies that fuel the market.

• In January 2021, Miravo Healthcare launched NeoVisc+ 2 mL and NeoVisc ONE 4 mL in Canada. NeoVisc+ and NeoVisc ONE are hyaluronic acid (HA) viscosupplements injected by a licensed healthcare professional into the knee joint.

Existing Restraints

Strict regulatory scenarios are expected to hamper the market. Orthopedic care is a lack of standardization in procedures, equipment, and protocols. To prove efficiency and safety, complete clinical and preclinical testing is required, and these tests are expensive and time-consuming, which impedes the orthopedic regenerative surgical products market.

Emerging Opportunities

Rising personalized medicine is expected to create lucrative opportunities for the market players. Personalized medicine is appropriate for the treatment of orthopedic patients and is relevant to increase accuracy and functional outcomes.

Patient's customized therapy regimes are increasingly relevant, owing to conservative and operative treatment approaches. The field of spine surgery is highlighting the effects of personalized medicine, owing to an increased understanding of spinal pathology and technological innovations, which have made personalized medicine a major component of patient care.

• In March 2023, Conformis Inc. launched a patient education and awareness campaign in the US to strengthen the importance of patient choice by highlighting the difference between traditional off-the-shelf products and truly personalized knee systems that offer clinically proven benefits to patients.

Scope of Orthopedic Regenerative Surgical Products Market Report

The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.

Orthopedic Regenerative Surgical Products Market Segment Insights

Application Segment Analysis

Based on application, the orthopedic regenerative surgical products market is divided into trauma repair, joint reconstruction, cartilage & tendon repair, and others. The joint reconstruction segment is expected to expand at a significant pace during the projection period, owing to the rising number of surgical procedures, increasing adoption of regenerative solutions in joint reconstruction, and technological advancements. People are concerned with health and well-being and frequently seek joint reconstruction to keep an active lifestyle even after joint-related accidents and degeneration.

The cartilage & tendon repair segment is anticipated to hold a key share of the market in the coming years, due to a large number of trauma cases, a rising number of older patients, and increasing applications in sports medicine. Improved imaging technology allows accurate diagnosis and monitoring of musculoskeletal conditions, allowing surgeons to improve and personalize their treatment plans.

Get Free Sample Report

Product Segment Analysis

In terms of product, the global market is segregated into synthetic, viscosupplements, cell-based, and allografts. The viscosupplements segment is further attributed to the amniotic products and others. The viscosupplements segment is projected to account for a major market share in the coming years, owing to the increasing incidence of osteoarthritis and knee pain management.

High demand for knee osteoarthritis, due to the benefits such as external injury, genetic predisposition, obesity, excessive exercise, and aging, which is boosting the segment. It is commonly preferred by healthcare facilities to treat osteoarthritis and benefits people with other kinds of arthritis such as rheumatoid arthritis therapeutics.

• In August 2021, Seikagaku Corporation launched HyLink, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis in Taiwan, through TCM Biotech International Corp. It is projected a long-lasting improvement of symptoms by an administration of only 3 ml.

The allografts segment is anticipated to register a considerable CAGR during the forecast period, due to the high usage of allografts in orthopedic regeneration operations. Allografts are used to restore and regenerate injured tissues during several minimally invasive procedures such as endoscopy and arthroscopy.

It is used in several surgeries to treat pain, save lives, restore limb function, and others. The segment is attributed to the rising uses of allografts including osteochondral allografts, soft tissue allografts, off-the-shelf cartilage, and fresh-frozen meniscal allografts.

• In August 2023, Stimlabs LLC, launched Relese a fenestrated dehydrated complete human placental membrane (dCHPM) allograft for acute and chronic wounds. Relese offers a thick, specialized allografts with excellent handling characteristics, making it ideal for various clinical applications.

Get Free Sample Report

End-user Segment Analysis

On the basis of end-user, the market is segmented into ambulatory surgical centers, hospitals, and others. The hospitals segment is expected to register a robust growth rate during the forecast period, owing to the increasing number of orthopedic procedures.

Hospitals are the primary revenue source for the healthcare sector and an integral part of the industry, which propels innovation and research. This, in turn, is likely to increase the demand for orthopedic surgeries in the segment.

The ambulatory surgical centers segment is projected to hold a large market share in the coming years, due to the high product usage for treatments and pain management. Ambulatory surgical centers are modern healthcare facilities that are focused on providing same-day surgical care including preventive and diagnostic procedures. The segment growth is attributed to the large number of ambulatory surgical centers (ASCs) for treating orthopedic patients.

Regional Analysis

In terms of region, the global orthopedic regenerative surgical products market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, owing to the rising technologically innovative healthcare facilities in the US and Canada and the growing geriatric population.

The regional market growth is attributed to the increasing adoption of regenerative orthopedics and rising incidences of orthopedic conditions. Emerging countries such as the US have the largest number of orthopedic regenerative surgical products suppliers and manufacturers to boost the segment. Several companies are launching products through acquisitions, mergers, and collaborations, which is expected to boost the market during the forecast period.

• In May 2021, MIMEDX Group Inc., partnered with Wake Forest Institute for Regenerative Medicine to develop and advance scientific evidence in support of safe and effective clinical therapies. This partnership reflects a shared vision to advance regenerative science and innovative biologics that restore quality of life for patients and is geared to further understanding product mechanisms of action and potential therapeutic targets.

The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, due to the increasing geriatric population. The regional market growth is further attributed to the rising prevalence of orthopedic ailments and the increasing development of healthcare infrastructure.

Regulatory approvals and clinical trials and the increasing consciousness of non-surgical alternatives to traditional orthopedic procedures are expected to boost the market.

• According to the National Institutes of Health (NIH), osteoarthritis is the second most common rheumatologic problem and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Osteoarthritis is more common in women than men; however, its prevalence is increasing drastically with age irrespective of the gender.

Get Free Sample Report